CARDIOVASCULAR JOURNAL OF AFRICA • Vol 21, No 2, March/April 2010
78
AFRICA
Becker C, Sevilla L, Tomàs E, Palacin M, Zorzano A, Fischer Y.
27.
The endosomal compartment is an insulin-sensitive recruitment site
for GLUT4 and GLUT1 glucose transporters in cardiac myocytes.
Endocrinolgy
2001;
142
(12): 5267–5276.
Holloszy JO. A forty-year memoir of research on the regulation of
28.
glucose transport into muscle.
Am J Physiol Endocrinol Metab
2003;
284
: E453–E467.
Hou J C and Pessin JE. Ins (endocytosis) and outs (exocytosis) of
29.
GLUT4 trafficking.
Curr Opin Cell Biol
2007;
19
: 466–473.
Furtado LM, Somwar R, Sweeney G, Niu W, Klip A. Activation of the
30.
glucose transporter GLUT4 by insulin.
Biochem Cell Biol
2002;
80
(5):
569–78.
Ishiki M, Klip A. Mini-review; recent developments in the regulation
31.
of glucose transporter-4 traffic: new signals, locations.
Endocrinology
2005:
146
: 5071–5078.
Koumanov F, Jun B, Yang J, Holman GD. Insulin signaling meets vesicle
32.
traffic of GLUT 4 at a plasma-mambrane-activated fusion step.
Cell
Metab
2005;
2
: 179–189.
Arias EB, Kim J, Funai K, Cartee GD. Prior exercise increases phospho-
33.
rylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle.
Am
J Physiol Endocrinol Metab
2006;
292
: E1191–E1200.
Donthi R, Huisamen B, Lochner A. The effect of vanadate and insulin on
34.
glucose transport in isolated adult rat cardiomyocytes.
Cardiovasc Drugs
Ther
2000;
14
: 463–470.
Armstrong S, Downey JM, Ganote CE. Preconditioning of isolated
35.
rabbit cardiomyocytes: induction by metabolic stress and blockade by
the adenosine antagonist SPT and calphostin C. a protein kinase C
inhibitor.
Cardiovasc Res
1994;
28
: 72–77.
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement
36.
with the Folin Phenol reagent.
J Biol Chem
1951;
193
(1): 265–275.
Bradford MM. A sensitive method for the quantification of protein
37.
utilizing the principle of protein-dye binding.
Anal Biochem
1976;
71
:
248–254.
Takeuchi K, McGowan FX Jr, Glynn P, Moran AM, Rader CM,
38.
Cao-Danh H,
et al
. Glucose transporter upregulation improves ischemic
tolerance in hypertrophied failing heart.
Circulation
1998;
98
(19 Suppl):
II-234–II-239.
Strijdom
39.
H, Muller C, Lochner A. Direct intracellular nitric oxide detec-
tion in isolated adult cardiomyocytes: flow cytometric analysis using
the fluorescent probe, diaminofluorescein.
J Mol Cell Cardiol
2004;
37
(4):897–902.
Javaux F, Vincent MF, Wagner DR, Van den Berghe G. Cell-type specifi-
40.
city of inhibition of glycolysis by 5-amino-4-imidazolecarboxamide
riboside. Lack of effect in rabbit cardiomyocytes and human erythro-
cytes, and inhibtion in FTO-2B rat hepatoma cells.
Biochem J
1995;
305
(Pt 3): 913–919.
Dimitriades G, Maratou E, Boutati E, Psarra K, Papasteriades C, Raptis
41.
SA. Evaluation of glucose transport and its regulation by insulin in human
monocytes using flow cytometry.
Cytometry Part A
2005;
64A
: 27–33.
Tanti J
42.
F, Grillo S, Grémeaux T, Coffer PJ, Van Obberghen E, Le
Marchand-Brustel Y. Potential role of protein kinase B in glucose
transporter 4 translocation in adipocytes.
Endocrinology
1997;
138
(5):
2005–2010.
Fryer LGD, Hajduch E, Rencurel F, Salt IP, Harinder S, Hundal D,
43.
et
al
. Activation of glucose transport by AMP-activated protein kinase
via stimulation of nitric oxide synthase.
Diabetes
2000;
49
: 1978–1985.
Strijdom H, Jacobs S, Hattingh S, Page C, Lochner A. Nitric oxide
44.
production is higher in rat cardiac microvascular endothelial cells
than ventricular cardiomyocytes in baseline and hypoxic conditions: A
comparative study.
FASEB J
2006;
20
(2): 314–316.
Lemieux K, Konrad D, Klip A, Marette A. The AMP-activated protein
45.
kinase activator AICAR does not induce GLUT4 translocation to trans-
verse tubules but stimulates glucose uptake and p38 mitogen-activated
protein kinases alpha and beta in skeletal muscle.
FASEB J
2003;
17
(12):
1658–1665.
Perrin C, Knauf C, Burcelin R. Intracerebroventricular infusion of
46.
glucose, insulin and the AMP-activated kinase activator AICAR controls
muscle glycogen synthesis.
Endocrinology
2004;
145
(9): 4025–4033.
Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, Allard MF.
47.
5-Aminoimidazole-4-carboxamide 1-beta -D-ribofuranoside (AICAR)
stimulates myocardial glycogenolysis by allosteric mechanisms.
Am J
Physiol Regul Integr Comp Physiol
2003;
284
(4): R936–R944.
Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases
48.
AMP-activated protein kinase, fatty acid oxidation, and glucose uptake
in rat muscle.
Am J Physiol
1997;
273
(6 Pt 1): E1107–E1112.
Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence
49.
for 5
′
AMP-activated protein kinase mediation of the effect of muscle
contraction on glucose transport.
Diabetes
1998;
47
(8): 1369-73.
Jessen N, Pold R, Esben S. Buhl, ES. Jensen LS, Schmitz O,
50.
et al
.
Effects of AICAR and exercise on insulin-stimulated glucose uptake,
insulin signalling and GLUT4 content in rat skeletal muscles.
J Appl
Physiol
2002;
10
: 1152.
Al-Khalili L, Krook A, Zierath JR, Cartee GD. Prior serum- and
51.
AICAR-induced AMPK activation in primary human myocytes does not
lead to subsequent increase in insulin-stimulated glucose uptake.
Am J
Physiol Endocrinol Metab
2004;
287
: E553–E557.
Fryer LGD, Hajduch E, Rencurel F, Salt IP, Harinder S, Hundal D,
52.
et
al
. Activation of glucose transport by AMP-activated protein kinase
via stimulation of nitric oxide synthase.
Diabetes
2000;
49
: 1978–1985.
Berger J, Hayes N, Szalkowski DM, Zhang B. PI 3-kinase activation is
53.
required for insulin stimulation of glucose transport into L6 myotubes.
Biochem Biophys Res Commun
1994;
205
(1): 570–576.
Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. Evidence
54.
for 5
′
AMP-activated protein kinase mediation of the effect of muscle
contraction on glucose transport.
Diabetes
1998;
47
(8): 1369–1373.
Fisher JS, Gao J, Han DH, Holloszy JO, Nolte LA. Activation of AMP
55.
kinase enhances sensitivity of muscle glucose transport to insulin.
Am J
Physiol
2002;
282
: E18–E23.
Beauloye C, Marsin AS, Bertrand L, Krause U, Hardie DG,
56.
Vanoverschelde JL,
et al
. Insulin antagonizes AMP-activated protein
kinase activation by ischemia or anoxia in rat hearts, without affecting
total adenine nucleotides.
FEBS Letts
2001;
505
(3): 348–352.
Sweeney G, Garg RR, Ceddia RB, Li D, Ishiki M, Somwar R,
57.
et
al
. Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate
causes incorporation of glucose transporter 4 into the plasma membrane
of muscle and fat cells without increasing glucose uptake.
J Biol Chem
2004;
279
(31): 32233–32242.
Funaki M, Randhawa P, Janmey PA. Separation of insulin signalling into
58.
distinct GLUT4 translocation and activation steps.
Mol Cell Biol
2004;
24
(17): 7567–7577.
Davey KAB, Garlick PB, Warley A, Southworth R. Immunogold label-
59.
ling study of the distribution of GLUT-1 and GLUT-4 in cardiac tissue
following stimulation by insulin of ischemia.
Am J Physiol Heart Circ
Physiol
2006;
292
: 2009–2019.
Thors
60.
B, Halldórsson H, Thorgeirsson G. Thrombin and histamine
stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177
via an AMPK mediated pathway independent of PI3K-Akt.
FEBS Letts
2004;
573
: 175–180.
Li J, Hu X, Selvakumar P, Russel RR III, Cushman SW, Holman GD,
61.
Young LH. Role of the nitric oxide pathway in AMPK-mediated glucose
uptake and GLUT4 translocation in heart muscle.
Am J Physiol
2004;
287
: E834–E841.
